MedTrace Logo

Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger

NCT07256522 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-19

No results posted yet for this study

Summary

Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks, along with a home exercise program. The second group will receive paraffin bath therapy, and the third group will receive peloidotherapy, both in combination with home exercises.

All patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patients will be instructed to avoid using analgesics within 24 hours prior to each assessment.

Conditions

  • Trigger Finger
  • Splint Therapy
  • Paraffin Bath
  • Peloidotherapy
  • Efficacy and Safety
  • Randomised Clinical Trial

Interventions

DEVICE

Finger orthosis

Joint-blocking finger orthosis plus home-based exercise therapy

OTHER

Paraffin bath

Paraffin bath plus home-based exercise therapy

OTHER

Peloidotherapy

Peloidotherapy plus home-based exercise therapy

Sponsors & Collaborators

  • Konya Beyhekim Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Ramazan Yilmaz, Assoc Prof · Konya Beyhekim Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2027-01-15
Completion
2027-02-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07256522 on ClinicalTrials.gov